分子分型时代乳腺癌的内科治疗——辅助治疗和姑息治疗在探索中前行
被引量:4
摘要
乳腺癌是女性最常见的恶性肿瘤之一,全世界每年约有130万新发病例,50万死亡病例。在西欧、北美等发达国家,乳腺癌发病率占女性恶性肿瘤首位。近年来我国乳腺癌发病率增长明显,目前国内患者人数已超过50万,在一些大城市已经位列女性肿瘤发病率首位。
出处
《中国癌症杂志》
CAS
CSCD
北大核心
2012年第10期796-800,共5页
China Oncology
二级参考文献11
-
1Sotiriou C,Pusztai L.Gene-expression signatures in breast cancer[J].N Engl J Med,2009,360(8):790-800.
-
2Perou CM,Serlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406 (6797):747-752.
-
3Desmedt C,Haibe Kains B,Wirapati P,et al.Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes[J].Clin Cancer Res,2008,14(16):5158-5165.
-
4Hugh J,Hanson J,Cheang MC,et al.Breast cancer subtypes and response to docetaxel in node-positive breast cancer:use of an immunohistochemical definition in the BCIRG 001 Trial[J].J Clin Oncol,2009,27(8):1168-1176.
-
5Hammond ME,Hayes DF,Dowsett M,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J].J Clin Oncol,2010,28(16):2784-2795.
-
6Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].J Clin Oncol,2007,25 (1):118-145.
-
7Hammond ME,Hayes DF,Wolff AC.Clinical notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER-2 testing in breast cancer[J].J Clin Oncol,2011,29 (15):e458.
-
8Goldhirsch A,Wood WC,Coates AS,et al.Strategies for subtypes-dealing with the diversity of breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J].Ann Oncol,2011.doi:10.1093/annonc/mdr304.
-
9Giuliano AE,Hunt KK,Ballman KV,et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis:a randomized clinical trial[J].JAMA,2011,305(6):569-575.
-
10Swain SM,Jeong JH,Wolmark N.Amenorrhea from breast cancer therapy-not a matter of dose[J].N Engl J Med,2010,363(23):2268-2270.
共引文献314
-
1李秀清.快速康复外科护理对乳腺癌改良根治术患者患肢功能恢复及并发症的影响[J].心理月刊,2019,0(24):34-35. 被引量:3
-
2陈菲,张蕾,李孙美.乳腺癌患者围术期护理服务需求特征及其关联性分析[J].生命科学仪器,2023,21(4):113-116. 被引量:2
-
3韩东兴,席吕刚,严琳,陈云霞,刘邦令.化疗对围绝经期乳腺癌患者性激素水平的影响[J].中国癌症杂志,2011,21(6):470-472. 被引量:3
-
4韩晓峰,任予,许建林,施常备.放射性硫胶体应用于乳腺癌前哨淋巴结活检的可行性分析[J].中华临床医师杂志(电子版),2012,6(16):4863-4864. 被引量:4
-
5原发性乳腺癌规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(5):30-37. 被引量:49
-
6刘琛,赵红佳,吴冬梅,杨娜.早、中期乳腺癌中医证型与腋窝淋巴结阳性数量的临床研究[J].福建中医药大学学报,2013,23(2):10-11. 被引量:1
-
7王永胜,孙晓.乳腺癌分期与术式选择[J].中华普外科手术学杂志(电子版),2011,5(4):5-9. 被引量:14
-
8黄宇康,彭伟强,翁剑华,吴楚成,颜宁,刘少杰.早期乳腺癌腋窝前哨淋巴结活检阴性保留腋窝淋巴结与腋窝淋巴结清扫的非随机对照临床研究[J].临床和实验医学杂志,2012,11(3):186-187. 被引量:11
-
9张殿龙,曹铭谦,王晓兰,姚永强,方红,解继平,程晓宇.Ⅰ、Ⅱ期乳腺癌保乳根治术加放疗的临床分析[J].中国现代医生,2012,50(7):55-57. 被引量:11
-
10程凯,蒋刚.复方苦参注射液辅助治疗乳腺癌的Meta分析[J].中国药房,2012,23(12):1128-1130. 被引量:3
同被引文献49
-
1黄红艳,江泽飞,王涛,张少华,边莉,曹阳,吴世凯,宋三泰.贝伐珠单抗联合多西他赛治疗Her-2阴性复发转移性乳腺癌的疗效观察[J].中国癌症杂志,2011,21(3):220-224. 被引量:18
-
2赵卫红,徐兵河,李青,张频,孙燕.70岁以上老年女性乳腺癌患者的特点和预后分析[J].中华肿瘤杂志,2006,28(5):385-388. 被引量:70
-
3PEROU C M, SORLIE T, EISEN M B, et al. Molecular portraits of human breast tumours [ J ] . Nature, 2000, 406(6797): 747-752.
-
4GOLDHIRSCH A, WINER E P, COATES A S, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2013 [ J ] . Ann Oncol, 2013, 24(9): 2206-2223.
-
5PARK S, KOO J S, KIM M S, et al. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry [ J ]. Breast, 2012, 21(1): 50-57.
-
6RIBELLES N, PEREZ-VILLA L, JEREZ J M, et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index [ J ] . Breast Cancer Res, 2013, 15(5): R98.
-
7KENNECKE H, YERUSHALMI R, WOODS R, et al. Metastatic behavior of breast cancer subtypes [ J ~ . J Clin Oncol, 2010, 28(20): 3271-3277.
-
8ZAHA D C, LAZAR E, L,~ZUREANU C. Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer [ J ] . Rom J Morphol Embryol, 2010, 51(1): 85-89.
-
9KENNECKE H F, OLIVOTTO I A, SPEERS C, et al. Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen [ J ] . Ann Oncol, 2007, 18(1): 45-51.
-
10EllisMJ, Llombart-CussacA, FeltlD, et al. Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: overall survival analysis from the phase Ⅱ first study[J]. J Clin Oncol, 2015, 61:5831.
引证文献4
-
1李新,刘薇.不同方案治疗复发转移性乳腺癌的疗效对比[J].中国卫生产业,2014,11(21):12-13. 被引量:2
-
2崔世恩,储兵,凌飞海.390例原发乳腺癌远处转移与分子分型关联性的10年回顾性分析[J].中国癌症杂志,2015,25(10):774-779. 被引量:17
-
3张金凤,胡夕春.激素受体阳性转移性乳腺癌的内分泌治疗[J].中华肿瘤杂志,2015,37(12):881-884. 被引量:7
-
4陈文辉,张振凯,李慧霞,关育栋,马瑞琳,吴琳静,王国英,王耀辉.旋毛虫抗原及旋毛虫感染小鼠血清对MCF-7细胞生长的抑制作用探讨[J].中国病原生物学杂志,2018,13(6):617-620. 被引量:3
二级引证文献29
-
1夏金,陈瑞萍,张彦芳,李江丽,牛春莲.诺维本联合铂类二线化疗治疗老年复发转移性乳腺癌的疗效分析[J].肿瘤药学,2015,5(3):209-212. 被引量:6
-
2张学勤,李逢春,汪秀玲.全数字化乳腺x线摄影对乳腺导管原位癌伴微浸润诊断的价值分析[J].徐州医学院学报,2016,36(9):601-603. 被引量:9
-
3易平,刘剑勇,张志明,周权,林家耀,陈兆飞,黄翀,向邦德,袁卫平.Luminal型乳腺癌术后肝转移患者预后因素分析[J].中华肿瘤防治杂志,2016,23(24):1619-1622. 被引量:5
-
4张英.沙利度胺联合卡培他滨节拍化疗治疗转移性乳腺癌的临床疗效及安全性分析[J].中外医疗,2017,36(3):142-144. 被引量:4
-
5罗安琪,韩瑞,吴芳,王冠英,张玉姣,景鑫,赵新汉.不同分子亚型乳腺癌骨转移患者的临床特征和预后分析[J].西安交通大学学报(医学版),2017,38(5):740-743. 被引量:4
-
6龚欢秀,沈奥林,夏东,蔡莉,程联胜,刘兢,程民,徐婷娟,胡世莲,沈国栋.高灵敏血清HER2蛋白检测方法的建立及临床应用[J].安徽医科大学学报,2017,52(11):1731-1735. 被引量:1
-
7李华民.EGFR、Ki67在三阴性与非三阴性乳腺癌中的表达及其与TNBC病理特征的相关性[J].实用癌症杂志,2017,32(11):1759-1762. 被引量:11
-
8洪蕾,毛慧,马富成.多种影像学技术在乳腺导管原位癌诊断中的应用研究[J].医学综述,2017,23(23):4741-4745. 被引量:3
-
9庄秀芬,张叔人,刘滨磊,吴基良,李小琴,顾汉刚,舒扬.携带重组人粒细胞巨噬细胞集落刺激因子的溶瘤性1型单纯疱疹病毒联合阿霉素治疗小鼠乳腺癌的效果[J].中华肿瘤杂志,2018,40(3):178-185. 被引量:1
-
10牛李敏,律慧敏,张梦玮,曾惠爱,闫敏.甲羟孕酮单药治疗激素受体阳性转移性乳腺癌102例[J].实用医学杂志,2018,34(7):1174-1178. 被引量:3